Literature DB >> 20938711

Anti-inflammatory defense mechanisms of Entamoeba histolytica.

Raúl Silva-García1, Guadalupe Rico-Rosillo.   

Abstract

The monocyte locomotion inhibitory factor (MLIF), a heat-stable oligopeptide found in the supernatant fluid of Entamoeba histolytica axenic cultures, may contribute to the delayed inflammation observed in amoebic hepatic abscess. This factor was isolated by ultra-filtration and high powered liquid chromatography, obtaining a primary Met-Gln-Cys-Asn-Ser structure, identified afterwards as the carboxyl-terminal (…Cys-Asn-Ser) active site. The selective anti-inflammatory effects of the pentapeptide have been observed in both in vitro and in vivo models, using a synthetic pentapeptide to maintain the same anti-inflammatory conditions during the experimental assays. Anti-inflammatory effects observed include inhibition of human monocyte locomotion and the respiratory burst in monocytes and neutrophils, increasing expression of anti-inflammatory cytokines and inhibiting expression of the adhesion molecules VLA-4 and VCAM, among others. In this review, we will describe the effects of MLIF detected so far and how it might be used as a therapeutical agent against inflammatory diseases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20938711     DOI: 10.1007/s00011-010-0261-x

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  55 in total

Review 1.  Therapeutic peptides.

Authors:  Samantha Lien; Henry B Lowman
Journal:  Trends Biotechnol       Date:  2003-12       Impact factor: 19.536

2.  An anti-inflammatory oligopeptide produced by Entamoeba histolytica down-regulates the expression of pro-inflammatory chemokines.

Authors:  Dolores Utrera-Barillas; Juan R Velazquez; Antonio Enciso; Samira Muñoz Cruz; Guadalupe Rico; Everardo Curiel-Quesada; Luis M Teran; Roberto R Kretschmer
Journal:  Parasite Immunol       Date:  2003-10       Impact factor: 2.280

3.  The structure of the follistatin:activin complex reveals antagonism of both type I and type II receptor binding.

Authors:  Thomas B Thompson; Thomas F Lerch; Robert W Cook; Teresa K Woodruff; Theodore S Jardetzky
Journal:  Dev Cell       Date:  2005-10       Impact factor: 12.270

4.  A novel anti-inflammatory oligopeptide produced by Entamoeba histolytica.

Authors:  R R Kretschmer; G Rico; J A Giménez
Journal:  Mol Biochem Parasitol       Date:  2001-02       Impact factor: 1.759

5.  Immunization with a tetramer derivative of an anti-inflammatory pentapeptide produced by Entamoeba histolytica protects gerbils (Meriones unguiculatus) against experimental amoebic abscess of the liver.

Authors:  Juan Antonio Giménez-Scherer; Guadalupe Cárdenas; Martha López-Osuna; Juan Raymundo Velázquez; Guadalupe Rico; Armando Isibasi; María del Carmen Maldonado; María Esther Morales; Jorge Fernández-Diez; Roberto R Kretschmer
Journal:  Parasite Immunol       Date:  2004 Aug-Sep       Impact factor: 2.280

6.  Inhibition of human monocyte locomotion by products of axenically grown E. histolytica.

Authors:  R Kretschmer; M L Collado; M G Pacheco; M C Salinas; M López-Osuna; M Lecuona; E M Castro; J Arellano
Journal:  Parasite Immunol       Date:  1985-09       Impact factor: 2.280

7.  Seroepidemiology of amebiasis in Mexico.

Authors:  A Caballero-Salcedo; M Viveros-Rogel; B Salvatierra; R Tapia-Conyer; J Sepulveda-Amor; G Gutierrez; L Ortiz-Ortiz
Journal:  Am J Trop Med Hyg       Date:  1994-04       Impact factor: 2.345

8.  Computational study of the electronic structure characterization of a novel anti-inflammatory tripeptide derived from monocyte locomotion inhibitory factor (MLIF)-pentapeptide.

Authors:  Carolina Barrientos-Salcedo; Guadalupe Rico-Rosillo; Juan Antonio Giménez-Scherer; Catalina Soriano-Correa
Journal:  Eur J Med Chem       Date:  2009-03-19       Impact factor: 6.514

9.  The plasmacytoma growth inhibitor restrictin-P is an antagonist of interleukin 6 and interleukin 11. Identification as a stroma-derived activin A.

Authors:  N Brosh; D Sternberg; J Honigwachs-Sha'anani; B C Lee; Y Shav-Tal; E Tzehoval; L M Shulman; J Toledo; Y Hacham; P Carmi
Journal:  J Biol Chem       Date:  1995-12-08       Impact factor: 5.157

10.  BABELOMICS: a suite of web tools for functional annotation and analysis of groups of genes in high-throughput experiments.

Authors:  Fátima Al-Shahrour; Pablo Minguez; Juan M Vaquerizas; Lucía Conde; Joaquín Dopazo
Journal:  Nucleic Acids Res       Date:  2005-07-01       Impact factor: 16.971

View more
  4 in total

1.  New monocyte locomotion inhibitory factor analogs protect against cerebral ischemia-reperfusion injury in rats.

Authors:  Xiaoping Wang; Chao Wang; Yan Yang; Jingman Ni
Journal:  Bosn J Basic Med Sci       Date:  2017-08-20       Impact factor: 3.363

2.  MLIF Alleviates SH-SY5Y Neuroblastoma Injury Induced by Oxygen-Glucose Deprivation by Targeting Eukaryotic Translation Elongation Factor 1A2.

Authors:  Qiuzhen Zhu; Yuefan Zhang; Yulan Liu; Hao Cheng; Jing Wang; Yue Zhang; Yaocheng Rui; Tiejun Li
Journal:  PLoS One       Date:  2016-02-26       Impact factor: 3.240

3.  Anti-Inflammatory Dipeptide, a Metabolite from Ambioba Secretion, Protects Cerebral Ischemia Injury by Blocking Apoptosis Via p-JNK/Bax Pathway.

Authors:  Qian Zhang; Jinwei Dai; Zhibing Song; Yuchen Guo; Shanshan Deng; Yongsheng Yu; Tiejun Li; Yuefan Zhang
Journal:  Front Pharmacol       Date:  2021-06-18       Impact factor: 5.810

4.  Monocyte locomotion inhibitory factor produced by E. histolytica improves motor recovery and develops neuroprotection after traumatic injury to the spinal cord.

Authors:  Gabriela Bermeo; Antonio Ibarra; Elisa García; Adrian Flores-Romero; Guadalupe Rico-Rosillo; Rubén Marroquín; Humberto Mestre; Carmina Flores; Francisco Blanco-Favela; Raúl Silva-García
Journal:  Biomed Res Int       Date:  2013-11-03       Impact factor: 3.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.